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Background: Polymorphisms in cytokine genes are known to influence cytokine levels, which may influence
susceptibility to tuberculosis (TB) infection and disease. Differences in cytokine expression probably determine
whether TB progresses, resolves, or becomes latent. In particular, the balance between the Th1 and Th2 cytokine
responses influences the expression of disease in individuals with pulmonary TB (PTB). We performed a case–control
study of 120 patients diagnosed with PTB, 240 with latent TB infection (LTBI), and 480 healthy controls (HC), to explore
the association between polymorphisms in cytokine genes and a predisposition to Mycobacterium tuberculosis infection
and TB disease.
Results: A single-gene analysis showed a dominant association between the AA genotype or A allele at nucleotide
−874 of the interferon γ (IFN-γ) gene and LTBI. The A allele at nucleotide −1082 of the interleukin 10 (IL-10) gene was
significantly more common in PTB patients than in LTBI subjects. Moreover, the polymorphisms at IFN-γ −874 and IL10
− 1082 were associated with protein levels of IFN-γ and IL-10, respectively, in the PTB group. The genotype frequencies
of other polymorphisms did not differ between the PTB patients, LTBI and HC subjects. Furthermore, combinations of
polymorphisms with IFN-γ −874 were associated with LTBI, whereas combinations with IL10 − 1082 were more likely
associated with PTB.
Conclusions: There are positive associations between the IFN-γ −874 polymorphism and TB and between the
IL10 − 1082 polymorphism and LTBI. Our data provide genetic evidence of the multiple disease hypothesis that many
cytokine genes are involved in TB susceptibility.
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Tuberculosis (TB) remains to be a leading cause of mor-
bidity and mortality in developing countries, and the
incidence of the disease is increasing in developed
countries [1]. One third of the world’s population is
infected by Mycobacterium tuberculosis (Mtb), but only
about 5% of infected individuals develop the disease
within the first year of infection and another 5% develop
the disease later in life. Candidate gene and association
studies have identified various host genetic factors that* Correspondence: bxu@shmu.edu.cn
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unless otherwise stated.play significant roles in susceptibility to TB [2,3]. Identify-
ing the host genes responsible for susceptibility and resist-
ance to TB may lead towards better understanding of the
pathogenesis of TB and development of prophylactic or
treatment strategies.
The cytokines produced at the site of disease after the
interaction between T lymphocytes and infected macro-
phages are essential for the pathogenesis of TB [4]. The
course of Mtb infection is regulated by two distinct T-cell
cytokine patterns. T-helper 1 (Th1) cytokines, interleukin
(IL)-2 and interferon γ (IFN-γ), are associated with re-
sistance to infection, whereas T-helper 2 (Th2) cyto-
kines, IL-4 and IL-13, are associated with progressive
disease [5]. Polymorphisms in several cytokine genes
have been described and shown to influence gene tran-
scription, leading to inter individual variations in cytokines is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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shown to be involved in the susceptibility, the severity and
clinical outcomes of several diseases, including infectious
diseases [7]. A single nucleotide polymorphism (SNP)
located in the first intron of human the IFN-γ gene
(+874 T⁄ A) putatively influences the secretion of the
cytokine, with an impact on the outcomes of infections.
This polymorphism displays variable associations with
TB disease susceptibility and severity [8] in some ethnic
populations but not in others [9]. A specific nucleotide
polymorphism within the promoter region of IL-10
(1082A⁄G) is also highly variable. This polymorphism al-
ters the level of this cytokine and possibly the Th1/Th2
balance, with major implications for TB infection [6].
Data on the association between the 1082G/A SNP of
IL-10 and TB are also highly variable. Among the proin-
flammatory cytokines, tumor necrosis factor α (TNF-α)
SNP −308 is associated with either TB susceptibility or
severity [10]. Furthermore, because the immune interac-
tions that determine TB disease susceptibility and sever-
ity are complex, multigene combinations may give more
meaningful information than single SNPs in determin-
ing disease outcomes [11].
Most studies have not differentiated TB disease ac-
cording to its natural history. Therefore, it is difficult
to evaluate the differences in their results. Our study
groups were stratified into latent TB infection (LTBI)
and active TB disease. We investigated the influence
of IFN-γ, TNF-α, and interleukin cytokine gene poly-
morphisms on the susceptibility of individuals to
LTBI and TB disease in terms of the cytokine levels
expressed and their associations with ex vivo stimu-
late cytokine and pulmonary TB in a population from
Shanghai. We also analyzed combinations of cytokine
gene polymorphisms.
Results
Demographic characteristics of the study groups
The study subject groups consisted of 120 newly diag-
nosed PTB patients, 240 subjects with LTBI, and 480
healthy control (HC) subjects. The mean ages and sex
distributions of the patients and controls did not differ.
The Bacille Calmette– Guérin (BCG) scar was observed
87.5% of PTB patients, 93.8% of the LTBI group, and
94.0% of HC subjects (Table 1).Table 1 Baseline information on the study groups
HC (n = 480) LTBI (n = 240)
Age (mean ± SD) 41.0 ± 19.9 43.0 ± 18.1
Sex (male) N(%) 294(61.2) 147(61.2)
BCG scar N(%) 451(94.0) 225(93.8)
Notes: SD, standard deviation; HC, healthy controls; LTBI, subjects with latent tuberc
Calmette–Guérin vaccine.
*p<0.05.Associations between Th1 cytokine polymorphisms and
TB susceptibility
The genotype distributions of the IFN-γ −874A/T SNP
and CA repeat did not deviate from Hardy–Weinberg
equilibrium in any subjects. At the IFN-γ T874A poly-
morphic site, the frequency of the A allele was 1.30-fold
higher in the LTBI than in the HC subjects (OR = 1.30;
95% CI: 1.020–1.664). The LTBI group had a signifi-
cantly higher proportion of the AA genotype than the
healthy group (OR = 1.39; 95% CI: 1.011–1.930). How-
ever, the PTB and LTBI groups had very similar fre-
quency distributions for the other −874A/T genotypes
and alleles. We identified 10 alleles for the CA repeat
polymorphism (ranging from 10 to 19 CA repeats). The
12, 13, and 15 CA repeats were found to be the most
common alleles in the study groups. The three groups
displayed similar distributions of the CA repeats, al-
though the TB group contained a significantly higher
proportion of the 12-repeat allele in the LTBI group
(OR = 1.71; 95% CI: 1.074–2.728). A haplotype analysis
revealed no significant differences in the IFN-γ A-12
haplotype frequency between the three groups. The
in vitro production of IFN-γ correlated with the
IFN-γ −874 polymorphism. IFN-γ levels were signifi-
cantly lower in the LTBI and PTB groups than in the HC
group (p = 0.001; Table 2, Figure 1).
In TNF-α, the frequencies of the TNF-α +488A,
−238A, and −308A alleles were 6.5%, 3.3%, and 4.7% in
the HC group, 7.1%, 3.3%, and 5.2% in the LTBI group,
respectively, and 10.0%, 4.6%, and 10.8% in the PTB
group, respectively. The number of individuals homozy-
gous for +488A was low and there were no homozygotes
for −238A or −308A in the PTB group. No significant
differences in the frequencies of the three polymorphic
variants of TNF-α were observed between the healthy
control and LTBI groups or between the LTBI and PTB
groups. The haplotype frequencies were similar between
the three groups. The levels of TNF-α were not related
to the TNF-α polymorphisms and were similar between
the three groups (Table 2, Figure 1).
At the −330 SNP of IL-2, a significant negative associ-
ation was evident between the TT genotype and the PTB
group compared with the LTBI group (28.3% vs 44.6%,
OR = 0.49, 95% CI: 0.297–0.806), whereas the G allele
was significantly overrepresented in the PTB group. APTB (n = 120) χ2/F p value
46.0 ± 12.2 0.141 0.234
74(61.7) 0.008 0.996
105(87.5) 6.440 0.040*
ulosis infection; PTB, patients with pulmonary tuberculosis; BCG, Bacillus
Table 2 Allele, genotype, and haplotype of Th1, Th2, and Th17 cytokine polymorphisms signficantly associated with
LTBI and TB
HC LTBI PTB LTBI.VS.HCS PTB.vs.LTBI
N(%) N(%) N(%) OR(95%CI) p value OR(95%CI) p value
IFN-r Genotypes
+874(A/T) AA 212(44.2) 126(52.5) 74(61.7) 1.39(1.011–1.930) 0.035* 1.46(0.910–2.337) 0.099
AT 201(41.9) 88(36.7) 36(30.0) 0.80(0.576–1.119) 0.131 0.74(0.448–1.213) 0.210
TT 67(14.0) 26(10.8) 10(8.3) 0.75(0.443–1.235) 0.171 0.75(0.311–1.676) 0.456
Alleles
A 625(65.1) 340(70.8) 184(76.7) 1.30(1.020–1.664) 0.029* 1.35(0.934–1.974) 0.097
T 335(34.9) 140(29.2) 56(23.3) 0.77(0.601–0.980) 0.029* 0.74(0.507–1.071) 0.097
CA repeats Alleles
12 641(66.8) 340(70.8) 186(77.5) 1.21(0.946–1.547) 0.119 1.71(1.074–2.728) 0.017*
Non-12 319(33.2) 140(29.2) 54(22.5) 0.83(0.647–1.057) 0.119 0.58(0.367–0.931) 0.017*
Haplotypes
(+874 and CA repeats) A-12 167(17.4) 103(21.5) 60(25.0) 1.30(0.975–1.721) 0.063 1.22(0.847–1.757) 0.284
T-12 174(18.1) 75(15.6) 30(12.5) 0.84(0.613–1.134) 0.237 0.77(0.472–1.238) 0.263
A-non12 324(33.8) 175(36.5) 98(40.8) 1.13(0.889–1.425) 0.309 1.20(0.864–1.672) 0.254
T-non12 295(30.7) 127(26.5) 52(21.7) 0.81(0.629–1.043) 0.093 0.77(0.521–1.126) 0.161
TNF-α Haplotypes
(238,308,488) A-A-A 1(0.2) 1(0.4) 0(0) 1.996(0.124–32.047) 1.000 – -
A-A-G 205(42.7) 102(42.5) 0(0) 0.984(0.720–1.346) 0.922 0.54(0.477–0.599) 0.000*
A-G-A 0(0) 0(0) 43(35.8) – 4.12(3.390–5.000) 0.000*
A-G-G 20(4.2) 10(4.2) 12(10.0) 0.996(0.459–2.162) 0.880 2.56(1.071–6.099) 0.029*
G-A-A 1(0.2) 1(0.4) 0(0) 1.996(0.124–32.047) 1.000 –
G-A-G 13(2.7) 7(2.9) 53(44.2) 1.075(0.423–2.730) 0.880 26.33(11.439–60.61) 0.000*
G-G-A 210(43.8) 105(43.8) 5(4.2) 0.993(0.727–1.356) 0.963 0.06(0.022–0.142) 0.000*
G-G-G 30(6.3) 15(6.3) 7(5.8) 0.996(0.525–1.888) 0.989 0.93(0.368–2.344) 0.876
IL2 Genotype
−330(T/G) GG 44(9.2) 29(12.1) 30(25.0) 1.210(0,742–1.969) 0.445 2.43(1.376–4.275) 0.002*
GT 256(53.3) 104(43.3) 56(46.7) 0.669(0.489–0.914) 0.011* 1.14(0.737–1.777) 0.549
TT 180(37.5) 107(44.6) 34(28.3) 1.34(0.966–1.858) 0.067 0.49(0.297–0.806)* 0.003*
Alleles
G 344(35.8) 162(33.8) 116(48.3) 0.91(0.724–1.149) 0.435 1.84(1.339–2.519) 0.000*
T 616(64.2) 318(66.2) 124(51.7) 1.10(0.865–1.391) 0.435 0.545(0.392–0.757)* 0.000*
−330 and −160 Haplotypes
G-G 205(21.4) 97(20.3) 48(20.1) 0.93(0.703–1.232) 0.615 0.99(0.655–1.475) 0.948
G-T 99(10.3) 68(14.1) 32(13.5) 1.44(1.015–2.021) 0.031* 0.93(0.573–1.493) 0.761
T-G 339(41.6) 95(39.5) 95(39.4) 0.45(0.344–0.590) 0.000* 2.66(1.856–3.793) 0.000*
T-T 317(26.7) 220(26.2) 65(27) 1.72(1.362–2.161) 0.000* 0.44(0.308–0.622) 0.000*
IL-12 genotypes
−1188(A/C) AA 270(56.2) 162(67.5) 80(66.7) 1.62(1.154–2.269) 0.004* 0.96(0.590–1.582) 0.874
AC 177(36.9) 65(27.1) 33(27.5) 0.66(0.460–0.933) 0.009* 1.02(0.603–1.712) 0.933
CC 33(6.9) 13(5.4) 7(5.8) 0.78(0.367–1.55) 0.451 1.08(0.355–3.011) 0.871
Alleles
A 717(74.7) 389(81.0) 193(80.4) 1.49(1.097–1.922) 0.007* 0.96(0.639–1.456) 0.841
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Table 2 Allele, genotype, and haplotype of Th1, Th2, and Th17 cytokine polymorphisms signficantly associated with
LTBI and TB (Continued)
C 243(25.3) 91(19.0) 47(19.6) 0.69(0.520–0.911) 0.007* 1.04(0.687–1.565) 0.841
IL-10 Genotypes
−1082(A/G) AA 262(54.6) 136(56.7) 82(68.3) 1.09(0.787–1.506) 0.596 1.65(1.016–2.699) 0.033*
AG 196(40.8) 86(35.8) 34(28.3) 0.81(0.579–1.128) 0.195 0.71(0.425–1.168) 0.155
GG 22(4.6) 18(7.5) 4(3.4) 1.69(0.834–3.368) 0.107 0.43(0.103–1.335) 0.120
−1082 and −819 Haplotypes
A-C 205(21.4) 116(24.2) 58(24.2) 1.17(0.896–1.533) 0.235 0.24(0.683–1.456) 1.000
A-T 100(10.4) 174(36.2) 95(39.6) 4.95(3.707–6.608) 0.000* 1.15(0.826–1.604) 0.383
G-C 400(41.7) 56(11.7) 26(10.8) 0.19(0.134–0.254) 0.000* 0.91(0.533–1.525) 0.740
G-T 255(26.6) 134(27.9) 61(25.4) 1.07(0.830–1.378) 0.601 0.88(0.607–1.268) 0.477
IL-6 Alleles
−174(G/C) G 674(70.2) 363(75.6) 182(75.8) 1.32(1.017–1.707) 0.031* 1.01(0.695–1.481) 0.951
C 286(29.8) 117(24.4) 58(24.2) 0.76(0.586–0.982) 0.031* 0.99(0.675–1.439) 0.951
genotypes
GG 247(51.5) 131(54.6) 66(55.0) 1.03(0.749–1.429) 0.429 1.02(0.640–1.620) 0.940
GC 180(37.5) 101(42.1) 50(41.7) 1.21(0.871–1.681) 0.235 0.98(0.614–1.569) 0.940
CC 53(11.0) 8(3.3) 4(3.3) 0.36(0.144–0.793) 0.000* 1.00(0.216–3.826) 1.000
Notes: HC, healthy controls; LTBI, subjects with latent tuberculosis infection; PTB, patients with pulmonary tuberculosis; INF-γ, interferon γ; TNF-α, tumor necrosis
factor α; IL-2, interleukin 1; IL-12, interleukin 12; IL-10, interleukin 10; IL-4, interleukin 4; IL-6, interleukin 6.
*p < 0.05.
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with the −330 GG genotype compared with the TG and
TT genotypes in culture filtrate (CFA)-stimulated cul-
tures of peripheral blood mononuclear cells (PBMCs)
from HC subjects (p = 0.35). No significant differences in
IL-2 levels were observed between the variant genotypes
of the IL2 polymorphism in the HC or the LTBI groups
(Figure 1).
Associations between Th2 cytokine polymorphisms and
TB susceptibility
Homozygosity for the IL-10 − 1082A allele occurred at a
higher frequency in the PTB group than in the LTBI
group (OR = 1.61, 95% CI: 1.071–2.438), indicating a sig-
nificant association between TB and the IL-10 − 1082
AA genotype (OR = 1.65, 95% CI: 1.061–2.699). No sta-
tistically significant difference was observed in the distri-
butions of the IL-10 − 1082 genotypes in the LTBI and
HC groups (p > 0.05). The distributions of the IL-10 −
819 genotypes were similar in the PTB patients, LTBI
and HC subjects (p > 0.05). There was no linkage be-
tween the −1082A/G and −819C/T IL10 polymorphisms.
The frequency of the IL-10 − 1082G/−819C haplotype
was lower in the LTBI subjects than in the HC (11.6% vs
41.6%, respectively; OR = 0.19, 95% CI: 0.134–0.254),
whereas the frequency of the IL-10 − 1082 A/−819 T
haplotype was higher (36.2% vs 10.3%, respectively; OR =
4.95, 95% CI: 3.707–6.608). However, the haplotype distri-
butions did not differ significantly between the LTBI andPTB subjects and the IL-10 levels did not differ among the
variant genotypes of the IL-10 gene polymorphisms in the
two groups (Table 3).
The allele and genotype frequencies of the IL-4 vari-
able number tandem repeat (VNTR) polymorphism did
not differ between the HC subjects and the PTB
patients. The IL-4 response was only detectable in a few
subjects. In the HC subjects, the IL-4 levels did not
differ among the variant genotypes of the IL-4 VNTR
polymorphism. However, among the PTB patients, there
was a trend towards an increased IL-4 response in
patients with the B2/B1 genotype compared with the
B2/B2 genotype under stimulated and unstimulated con-
ditions (CFA, p = 0.066; Table 2, Figure 1).
Associations between the Th17 cytokine polymorphism
and TB susceptibility
For the IL6 polymorphism at nucleotide −174, the CC
genotype was significantly lower (3.3% vs 11.0%, respect-
ively; OR = 0.36; 95% CI: 0.144–0.793) compared to HC
group and the G allele was overrepresented in the LTBI
group. IL-6 levels did not differ significantly between the
genotypes of the IL-6 − 174G/C SNP in the HCs and
patients.
Multilocus genotype association with the risk of LTBI and
development of TB
We also assessed whether genotype combinations (in
IFN-γ, TNF-α, IL-10, and IL-2) for the mutations in these
Figure 1 Influence of cytokine polymorphism on culture filtrate (CFA) of M.tuberculosis-induced cytokine production in healthy
controls, LTBI and PTB patients.
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Table 3 Association between combinations of cytokine gene polymorphisms and susceptibility to LTBI and PTB
INF-γ TNF-a IL-10 IL-2 HC LTBI PTB LTBI.vs.Health PTB.vs.LTBI
874 −308 −1082 −330 OR(95%CI) OR(95%CI)
1 A A A G 56 30 12 1.07(0.657-1.734) 0.79(0361–1.624)
2 A A A T 113 47 43 0.81(0.555-1.178) 2.01(1.252-3.219)*
3 A A G T 50 41 5 1.70(1.079-2.665)* 0.23(0.069-0.588)
4 A G A G 70 32 22 9.25(5.300-15.932)* 1.41(1.062-2.575)*
5 A G A T 105 67 46 1.32(0.936-1.855) 1.46(0.994-2.248)
6 A G G G 29 28 7 1.98(1.125-3.505)* 0.48(0.176-1.159)
7 A G G T 44 26 11 1.19(0.695-2.009) 0.84(0.367-1.795)
8 T A A G 29 20 9 2.47(1.300-4.599)* 0.89(0.353-2.101)
9 T A A T 64 32 11 1.00(0.623-1.578) 0.67(0.300-1.400)
10 T A G G 35 11 7 0.62(0.281-1.263) 0.33(0.107-1.945)
11 T A G T 71 30 8 0.83(0.518-1.319) 0.52(0.202-1.179)
12 T G A G 24 19 9 1.61(0.823-3.093) 0.95(0.371-2.236)
13 T G A T 85 43 17 1.01(0.673-1.508) 0.77(0.405-1.425)
14 T G G G 38 20 6 1.05(0.574-1.884) 0.59(0.191-1.550)
15 T G G T 124 28 16 0.42(0.263-0.645) 1.15(0.570-2.259)
Notes: HC, healthy controls; LTBI, subjects with latent tuberculosis infection; PTB, patients with pulmonary tuberculosis; INF-γ, interferon γ; TNF-α, tumor necrosis
factor α; IL-10, interleukin 10; IL-2, interleukin 2.
*p < 0.05.
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There were 15 possible combinations. There was a clear
association between IFN-γ −874A and latent TB, espe-
cially in the combinations AAGT (OR = 1.70; 95% CI:
1.079–2.665), AGAG (OR = 9.25; 95% CI: 5.300–15.932),
and AGGG (OR = 1.98; 95% CI: 1.125–3.505), whereas
IL-10 − 1082 was associated with an increased risk of
PTB in the combination of AAAT (OR = 2.01; 95% CI:
1.252–3.219) and AGAG (OR = 1.41; 95% CI: 1.062–2.575;
(Table 3).Dose effects of genes and gene–environment interactions
In addition to the multiplicative and additive models, we
also analyzed the dose effects of the genotypes using the
dominant and recessive models for each of the four ge-
notypes and their interactions with BCG (Table 4). The
effect of the IFN-γ +874 T allele was recessive for LTBI,
whereas IFN-γ +874 T was dominant for PTB. The
TNF-α and IL-2 polymorphisms were not significant in
these models (Table 4). BCG vaccination was found to
compensate for the positive effect of the IFN-γ poly-
morphism and was associated with a reduced risk of
LTBI in the additive model.Discussion
SNPs in several candidate genes have been linked to an
increased risk of TB [12]. In this polymorphism associ-
ation study, we investigated the significance of the rela-
tionship between several cytokine gene polymorphisms,their plasma products, and susceptibility to TB in a
Chinese population.
The IFN-γ polymorphism is the best-studied poly-
morphism in terms of its association with TB disease
sites and severity. However, previous reports have been
contradictory insofar as the −874A allele was more com-
mon in patients with TB and the T allele was more com-
mon in the controls in Italian [13], South African [14],
and Spanish populations [15], whereas in China, one
study reported no association [16] while a later study of
the same population showed an association between TB
and the A allele [17]. Our results are consistent with the
latter study. In the present report, we show that the A
allele at IFN-γ −874A/T was significantly overrepre-
sented in the populations of LTBI and PTB patients,
with A allele frequencies 1.30-fold and 1.76 fold higher,
respectively, than those in the HC. Significantly reduced
IFN-γ production by stimulated PBMCs was observed in
individuals with the A allele at IFN-γ −874. Similar
genotype distributions and associations were observed
for the t875 CA repeats (non-12/12) as at −874A/T in
our study, and the non-12 CA repeats allele was abso-
lutely linked to the −874 A allele in our population, as
previously reported in a UK population. Because the
−874 A allele corresponds to lower IFN-γ expression,
the lower IFN-γ levels may impair the activation of mac-
rophages, resulting in the development of TB. These ob-
servations indicate that the A allele at IFN-γ −874, or
another nearby genetic variation linked to it, increases
the host’s susceptibility to TB.
Table 4 Dose effects of gene–gene and gene–environment interactions on susceptibility to LTBI and PTB
Cytokines SNP position Genotypes LTBI.vs.HC PTB.vs.LTBI
Gene Gene*BCG Gene Gene*BCG
IFNγ (+874)T- > A Additive 0.092 0.093 0.264 0.093
Dominant 0.616 0.193 0.010* 0.117
Recessive 0.003* 0.277 0.552 0.405
Multiplicative 0.174 0.382 0.976 0.979
IL-10 (−1082)G- > A Additive 0.015 0.909 0.540 0.466
Dominant 0.485 0.837 0.208 0.507
Recessive 0.880 0.775 0.098 0.709
Multiplicative 0.423 0.749 0.134 0.411
TNFα (−308)A- > G Additive 0.845 0.722 0.945 0.873
Dominant 0.995 1.000 0.995 0.999
Recessive 0.072 0.326 0.144 0.700
Multiplicative 1.000 0.999 0.995 0.994
IL2 Additive 0.815 0.909 0.437 0.485
Dominant 0.485 0.837 0.845 0.613
Recessive 0.881 0.775 0.253 0.223
Multiplicative 0.423 0.749 0.577 0.397
Notes: HC, healthy controls; LTBI, subjects with latent tuberculosis infection; PTB, patients with pulmonary tuberculosis; INF-γ, interferon γ; IL-10, interleukin 10;
TNF-α, tumor necrosis factor α; IL-2, interleukin 2.
*p < 0.05.
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seems to influence the susceptibility of the host to TB in-
fection [18], identifying the polymorphisms in the IL-10
gene may be useful in predicting disease susceptibility.
The frequency of the IL-10 − 1082G allele in our popula-
tion (4%) was similar to that in Korean (7.4%) [19] and
Japanese (6.5%) populations [20], but was significantly dif-
ferent from that reported in Caucasians (48%) [21]. The
present results also show that the genotype frequency of
the IL-10 − 1082A allele was significantly increased in TB
patients compared with the LTBI subjects, especially when
it was associated with the IFN-γ +874A allele (OR = 3.59;
p = 0.045). This is consistent with the low levels of
mycobacterial-stimulated IFN-γ and IL-10 in PTB pa-
tients. In fact, there remains a discrepancy with the −1082
polymorphism in the IL10 promoter, for which no associ-
ation with TB was reported in Gambian [22] and Korean
populations [23]. However, an association between the IL-
10 − 1082A allele and TB was observed in an Italian (Sicil-
ian) [24] population, and GA heterozygosity was associ-
ated with PTB in Cambodia [25]. These observations may
reflect ethnic-specific genetic variations or suggest that
other more-distal promoter elements are involved.
A number of studies have investigated the association
between the TNF-α 308 (rs1800629 G/A) polymorphism
and susceptibility to TB in different populations. How-
ever, the association between TB with TNF-α differs with
ethnicity, and many of these studies have produced in-
consistent results [26]. In the present study, a significantnegative association between TB and the TNF-α 308 GA
genotype and a significant positive association with the
GG genotype were found, and the G allele was carried
by 90% of patients and by 85.8% of controls. The A allele
is associated with high TNF-α production and the G al-
lele is associated with low TNF-α production. The high
frequency of the genotype associated with increased pro-
tein production may be attributable to selection during
the course of evolution, increasing the frequency of the
most advantageous genotype. Our data indicate that
TNF-α production was reduced in our PTB patients.
Although the study by Scola et al. demonstrated a re-
duction in the low-producing −308 G/G TNF-α homo-
zygous individuals in the affected group [24], and the
study of Bikmaeva et al. revealed an association be-
tween the high-producing A allele and a higher risk of
PTB [27], although several studies have failed to con-
firm the association between TNF-α and TB [28].
In the present study, we also analyzed several other
candidate gene polymorphisms and their association
with the susceptibility to PTB or LTBI. We found a sig-
nificant negative association between the −330 TT geno-
type of IL-2 and PTB; the T allele was significantly
overrepresented in the LTBI group and the HC relative
to the PTB group. This suggests that the GG haplotype
is associated with a susceptibility to PTB. Although
translation studies have demonstrated the increased
activity of the G allele, allele expression studies have shown
higher expression of IL-2 in the PBMCs of individuals
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uals with the GG genotypes, suggesting that the IL-2 pro-
moter activity is also influenced by other polymorphisms,
probably +160 T/G [29]. No significant association be-
tween TB and IL-4 levels was observed for the VNTR
polymorphism. The results of the present study do not
preclude the possible influence of the VNTR poly-
morphism on the IL-4 response because IL-4 was un-
detectable in most of the subjects tested, which could
be attributable to the downregulation of the Th2 re-
sponses by the IFN-γ secreted in response to the anti-
gens used. In our study, the IL-6 − 174 CC genotype was
significantly negatively associated with the LTBI group
and with the reduced production of IL-6. In previous
studies, significant levels of IL-6 were shown to be pro-
duced in response to Mtb infection. Human and murine
macrophages secrete IL-6 in response to Mtb in vitro
[30], and elevated concentrations of IL-6 are present in
the plasma of patients with TB [31]. It has also been re-
ported that the induction of IL-6 activity by Mtb inhibits
IFN-γ signaling, so the bacterium evades eradication by
the cellular immune response [32]. We have reported
that the IL-12 AA genotype is associated with LTBI sus-
ceptibility. This is consistent with reports from Japan
and France, where polymorphisms in the IL-12 receptor
β1 gene (IL-12RB1) are known to influence the suscepti-
bility to and severity of TB [33].
A consensus seems to be emerging that the combined
effects of several cytokine SNPs may play a crucial role
in susceptibility to LTBI and TB diseases [29]. The com-
bination of the IFN-γ polymorphism with other cytokine
polymorphisms was most effective in predicting LTBI.
This observation is consistent with the recently de-
scribed functions of IFN-γ in a mouse model, in which
mice with a disrupted IFN-γ gene were unable to control
Mtb infection [34]. The combination of IL-10 polymor-
phisms with other cytokine polymorphisms may predict
a susceptibility to TB. These results also substantiate an
earlier report [35] that implicated IL-10 in the reactiva-
tion of TB in humans and in TB disease in a mouse
model. A recently published meta-analyses reinforced
the critical importance of IFN-γ +874 T/A as a genetic
marker of TB resistance [8], and stressed that although
IL-10 has a specific effect on the form and severity TB,
it does not affect susceptibility per se. Our results are
consistent with these findings. BCG vaccination cannot
be ignored [36]. However, we found no evidence that
BCG vaccination interacts with gene polymorphisms in
affecting susceptibility to TB.
In this study, all cases of TB disease were included,
but the majority of patients had PTB. Therefore, it was
not possible to demonstrate an association between the
system involved and cytokine polymorphisms. A larger
series is required to test the possible associationsbetween cytokine gene polymorphisms and organ prefer-
ence in TB, and the clinical severity of the disease.
Conclusions
Single-nucleotide functional polymorphisms in cytokine
genes display variable associations with LTBI and active
TB disease. Combinations of cytokine SNPs with the
IFN-γ +874 T/A SNP markedly influence the severity
and outcome of TB. Our results may reflect the poly-
genic aspects of a predisposition to severe and active TB.
Methods
Study subjects
Two case–control studies consisted of 120 patients diag-
nosed with PTB (patient group), 240 with LTBI (the
control group for the patient group, and the case group
for the HC group), and 480 HC individuals (control
group). The subjects were recruited during the routine
investigation of individuals in contact with TB in seven
districts of Shanghai between 2009 and 2010. The sub-
jects in the patient group were bacteriologically con-
firmed as TB patients infected with Mtb. None of the
patients reported infection with human immunodefi-
ciency virus. LTBI was identified in the contacts of TB
patients, and had no TB-related symptoms but a positive
T-SPOT.TB test. The subjects in the HC group were also
recruited from the contacts of TB patients, with no
TB-related symptoms or previous history of TB, and a
negative T-SPOT.TB test.
T-SPOT.TB assays
T-SPOT.TB assays were performed according to the
manufacturer’s instructions (Oxford Immunotec, Oxford,
UK). Briefly, PBMCs were isolated from whole blood by
centrifugation with Lymphocyte Separation Medium
(Ficoll 400), washed twice, and incubated with ESAT-6
and CFP-10 antigens for 16–20 h (37°C, CO2) in an
enzyme-linked immunosorbent spot assay. The spots were
counted. The T-SPOT.TB result was positive when the
number of spots in the test well (against at least one of the
two tested antigens) was at least six, if the negative control
had fewer than five spots, or twice the number of spots in
the negative control wells, if the negative control had
more than six spots. This cutoff was predefined in the
manufacturer’s instructions.
Whole blood stimulation assays
The stimulated whole blood (WB) culture assay used to
assess the cytokine profiles has been described in detail
previously [37]. Briefly, heparinized blood was diluted
1:11 with sterile RPMI 1640 tissue culture medium con-
taining 100 units/ml penicillin/100 mg/ml streptomycin
and 2 mM L-glutamine (Sigma Chemical Co., St. Louis,
MO, USA). Within 2 h of collection, diluted WB
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proteins (5 mg/ml) in a 24-well tissue culture plate. The
supernatants were collected from the wells at varying
intervals.
Cytokine assessment
The cytokines in the supernatants were assessed using
pairs of monoclonal antibodies, as described in detail
previously [38]. Dose–response curves were constructed
for each individual plate. The supernatants were serially
diluted and the optical density (OD) readings in the linear
ranges of the dose–response curves were used to calculate
the concentrations. The final concentrations (pg/ml) were
obtained by multiplying the values by the dilutions at
which the ODs were read. The sensitivity range of cyto-
kine detection was 7.5–1000 pg/ml and was similar to that
reported by the manufacturer.
Molecular methods
Genomic DNA was extracted from blood samples with
the Puregene Genomic DNA Isolation Kit (Gentra
Systems, Minneapolis, MN, USA), according to the
manufacturer’s instructions. Primers were purchased
from MWG-Biotech AG (Ebersberg, Germany). IFN-γ
(rs2430561), IL-10 (rs1800896), and TNF (rs1800629)
were genotyped with amplification-refractory muta-
tion system–polymerase chain reaction (ARMS-PCR),
with human growth hormone or bactin primers as the
internal controls to check the accuracy of the PCR re-
actions. IL-6 (rs1800795) was genotyped with tetra-
ARMS-PCR. The amplified products (5 ul, undiluted)
were monitored with electrophoresis on agarose gel
prepared in Tris–acetate ethylene-diaminetetraacetic
acid (TAE) buffer containing 10 mg/ml ethidium bromide.
The product bands were visualized on a UV transillu-
minator and photographs were taken for genotype
interpretation.
Confirmatory sequencing methodology
DNA sequencing was applied to a subset of samples
(10%–15% for each SNP) to confirm the genotypes iden-
tified with ARMS and tetra-ARMS-PCR. The primers
used for the sequencing reactions for IFN-γ and IL-10
were designed using the Lasergene version 7.0 software
(DNASTAR, Madison, WI, USA), and the primers for
TNF and IL-6 were designed using the web-based Batch-
Primer3 software. Sequence data produced with the ABI
3130xl Genetic Analyzer were reviewed for confidence
levels with the ABI Sequence Scanner software, and the
sequencing results were analyzed with pairwise align-
ments of the sequences with ClustalW version 1.83. The
allelic specificities of the cytokine gene SNPs were deter-
mined by comparison of the PCR results with thenucleotide sequencing results for the alleles. Concord-
ance of > 95% was observed in all cases.
Statistical analysis
Data were analyzed with SPSS for Windows version 16
(SPSS Inc., Chicago, IL, USA). The cytokine levels were
expressed as means ± standard error. Hardy–Weinberg
proportions were determined by applying the equation
(p2 + 2pq + q2). All polymorphisms were tested for
Hardy–Weinberg equilibrium separately in the patient
and control groups by comparing observed and ex-
pected numbers using the χ2 test. The distributions of
the cytokine gene polymorphisms were compared be-
tween the different study groups with the χ2 test or
Fisher’s exact test if a cell was below 5. Values of p
were smaller than 0.05 were considered significant.
Odds ratios (OR) and 95% confidence intervals (CI)
were also calculated. A logistic regression analysis was
used to determine the effects of age and sex on the ge-
notypes. Combinations of the IFN-γ +874 TA genotype
with the IL10 21082 AG, TNF −308 GA, or IL-6 2174
GC genotype were used to determine the two-gene
combination effects. Nine possible genotypes were
compared between the controls and PTB patients
using Pearson’s χ2 or Fisher’s exact test.
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